Waverly Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Waverly Advisors's NVO Position: Q3 2026 in Review
Waverly Advisors increased its Novo Nordisk (NVO) stake by 21% in Q3 2026, buying an estimated $90.6K and bringing the position to 11,520 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.
Waverly Advisors first reported a position in NVO in Q3 2013 and has held it in 23 quarters since. The position peaked at $6.32M in Q1 2025. 1,227 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Waverly Advisors held 11,520 shares of Novo Nordisk worth $437K as of Q3 2026.
- Waverly Advisors bought 1,966 Novo Nordisk shares in Q3 2026, an estimated $90.6K.
- Novo Nordisk made up ﹤0.01% of Waverly Advisors's portfolio in Q3 2026, its #1280 holding.
- Waverly Advisors first reported a position in Novo Nordisk in Q3 2013 and has held it in 23 quarters since.
- Waverly Advisors's Novo Nordisk position peaked at $6.32M in Q1 2025.
- 1,227 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Waverly Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.